‘There is relief and gratitude among our teams today’: Gilead CEO says positive results from Ebola drug remdesivir trial mark important progress in hunt for coronavirus treatment
Daily Mail | ‘Positive data’ from a National Institutes of Health (NIH) trial of remdesivir sent the stock market soaring by 530 points on Wednesday.
Leave a Reply